235 related articles for article (PubMed ID: 29414447)
1. Physical ability of people with rheumatoid arthritis and age-sex matched controls to use four commonly prescribed inhaler devices.
Kafaei Shirmanesh Y; Jones MD
Respir Med; 2018 Feb; 135():12-14. PubMed ID: 29414447
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
[TBL] [Abstract][Full Text] [Related]
3. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
[TBL] [Abstract][Full Text] [Related]
4. First-time handling of different inhalers by chronic obstructive lung disease patients.
Harb HS; Laz NI; Rabea H; Abdelrahim MEA
Exp Lung Res; 2020 Sep; 46(7):258-269. PubMed ID: 32614625
[No Abstract] [Full Text] [Related]
5. Administration Technique and Acceptance of Inhaler Devices in Patients With Asthma or COPD.
Sadowski CA; Cor K; Cave A; Banh HL
Ann Pharmacother; 2015 Jun; 49(6):639-48. PubMed ID: 25814632
[TBL] [Abstract][Full Text] [Related]
6. A comparison of large volume spacer, breath-activated and dry powder inhalers in older people.
Jones V; Fernandez C; Diggory P
Age Ageing; 1999 Sep; 28(5):481-4. PubMed ID: 10529044
[TBL] [Abstract][Full Text] [Related]
7. Use of dry powder inhalers in COPD.
Wilson DS; Gillion MS; Rees PJ
Int J Clin Pract; 2007 Dec; 61(12):2005-8. PubMed ID: 17997806
[TBL] [Abstract][Full Text] [Related]
8. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.
van der Palen J; Thomas M; Chrystyn H; Sharma RK; van der Valk PD; Goosens M; Wilkinson T; Stonham C; Chauhan AJ; Imber V; Zhu CQ; Svedsater H; Barnes NC
NPJ Prim Care Respir Med; 2016 Nov; 26():16079. PubMed ID: 27883002
[TBL] [Abstract][Full Text] [Related]
9. Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research.
Mahon J; Fitzgerald A; Glanville J; Dekhuijzen R; Glatte J; Glanemann S; Torvinen S
Respir Med; 2017 Aug; 129():98-116. PubMed ID: 28732842
[TBL] [Abstract][Full Text] [Related]
10. Assessment of patient performance of the HandiHaler compared with the metered dose inhaler four weeks after instruction.
Dahl R; Backer V; Ollgaard B; Gerken F; Kesten S
Respir Med; 2003 Oct; 97(10):1126-33. PubMed ID: 14561020
[TBL] [Abstract][Full Text] [Related]
11. Inhaler devices in asthma and COPD patients - a prospective cross-sectional study on inhaler preferences and error rates.
Schreiber J; Sonnenburg T; Luecke E
BMC Pulm Med; 2020 Aug; 20(1):222. PubMed ID: 32819337
[TBL] [Abstract][Full Text] [Related]
12. Device-handling study of a novel breath-actuated inhaler, Synchrobreathe®, versus a pMDI.
Balamurugan S; Apte K; Singh BP; Deb AK; Deshmukh C; Modi K; Godse A; Dhar R; Lahiri KR; Singh V; Pandya H; Rajan S; Vaidya A; Gaur V; Gogtay J
Respir Med; 2020 Jan; 161():105707. PubMed ID: 32056719
[TBL] [Abstract][Full Text] [Related]
13. New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferences.
Ninane V; Vandevoorde J; Cataldo D; Derom E; Liistro G; Munghen E; Peché R; Schlesser M; Verleden G; Vincken W
Respir Med; 2015 Nov; 109(11):1430-8. PubMed ID: 26439177
[TBL] [Abstract][Full Text] [Related]
14. The ability of people with intellectual disability to use inhalers--an exploratory mixed methods study.
Davis S; Durvasula S; Merhi D; Young P; Traini D; Bosnic-Anticevich S
J Asthma; 2016; 53(1):86-93. PubMed ID: 26365005
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
[TBL] [Abstract][Full Text] [Related]
16. Determinants of incorrect inhaler technique in chronic obstructive pulmonary disease patients.
Harb HS; Ibrahim Laz N; Rabea H; Abdelrahim MEA
Int J Clin Pract; 2021 Jun; 75(6):e14073. PubMed ID: 33559260
[TBL] [Abstract][Full Text] [Related]
17. Dry powder inhalers: which factors determine the frequency of handling errors?
Wieshammer S; Dreyhaupt J
Respiration; 2008; 75(1):18-25. PubMed ID: 17911976
[TBL] [Abstract][Full Text] [Related]
18. Evaluating inhaler use technique in COPD patients.
Pothirat C; Chaiwong W; Phetsuk N; Pisalthanapuna S; Chetsadaphan N; Choomuang W
Int J Chron Obstruct Pulmon Dis; 2015; 10():1291-8. PubMed ID: 26185435
[TBL] [Abstract][Full Text] [Related]
19. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
20. Optimizing drug delivery in COPD: The role of inhaler devices.
Rogliani P; Calzetta L; Coppola A; Cavalli F; Ora J; Puxeddu E; Matera MG; Cazzola M
Respir Med; 2017 Mar; 124():6-14. PubMed ID: 28284323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
